Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies

Turn Biotechnologies, Inc. California

Synergistic collaboration to revolutionize age-related therapies worldwideand connect with us on LinkedIn. For any media inquiries, please contact HanAll PR/IR ([e-mail], [e-mail]).

FOR MORE INFORMATION, CONTACT:

Jim Martinez, rightstorygroup

[e-mail] or [phone]

Logo - https://mma.prnewswire.com/media/1935529/TURN_LOGO_HI_RES_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/turn-biotechnologies-signs-global-licensing-agreement-with-hanall-biopharma-to-develop-eye-and-ear-therapies-302156424.html